Volume 51, Issue 1, Pages 67-74 (January 2007) Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic Review Paramananthan Mariappan, Ammar Alhasso, Zoe Ballantyne, Adrian Grant, James N'Dow European Urology Volume 51, Issue 1, Pages 67-74 (January 2007) DOI: 10.1016/j.eururo.2006.08.041 Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 1 Numbers cured during treatment: Duloxetine vs placebo. European Urology 2007 51, 67-74DOI: (10.1016/j.eururo.2006.08.041) Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 2 Numbers improved during treatment: Duloxetine vs placebo. European Urology 2007 51, 67-74DOI: (10.1016/j.eururo.2006.08.041) Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 3 Assessment of I-QoL change: Duloxetine vs placebo. European Urology 2007 51, 67-74DOI: (10.1016/j.eururo.2006.08.041) Copyright © 2006 European Association of Urology Terms and Conditions
Fig. 4 Adverse events and discontinuation rates: Duloxetine vs placebo. European Urology 2007 51, 67-74DOI: (10.1016/j.eururo.2006.08.041) Copyright © 2006 European Association of Urology Terms and Conditions